Dehydroepiandrosterone-dependent induction of peroxisomal proliferation can be reduced by aspartyl esterification without attenuation of inhibitory bone loss in ovariectomy animal model.
The purpose of this study was to determine whether esterification of dehydroepiandrosterone with aspartate (DHEA-aspartate) could reduce peroxisomal proliferation induced by DHEA itself, without loss of antiosteoporotic activity. Female Sprague-Dawley rats were ovariectomized, then DHEA or DHEA-aspa...
Main Authors: | Kwak, C. S., Kang, C. M., Kang, H. S., Song, K. Y., Lee, M. S., Seong, S. C., Park, S. C. |
---|---|
Format: | Online |
Language: | English |
Published: |
Korean Academy of Medical Sciences
2000
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054677/ |
Similar Items
-
The induction of liver growth by peroxisome proliferators
by: Al Kholaifi, Abdullah
Published: (2008) -
Molecular Mechanisms Associated with the Induction of Ubiquinone by Peroxisome Proliferators
by: Khan, Seher Akhtar
Published: (2009) -
In vivo induction of neutrophil chemotaxis by secretory aspartyl proteinases of Candida albicans
by: Gabrielli, Elena, et al.
Published: (2016) -
Dehydroepiandrosterone exerts antiglucocorticoid action on human preadipocyte proliferation, differentiation, and glucose uptake
by: McNelis, Joanne C., et al.
Published: (2013) -
The Role of Peroxisome Proliferator-Activated Receptors in Colorectal Cancer
by: Park, Joo-In, et al.
Published: (2012)